EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for OMER.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Edgewise Therapeutics, Inc. -0.4737
Boston Scientific Corp. 0.4493
Gilead Sciences, Inc. 1.742
Merck & Co., Inc. 1.191
REGENXBIO, Inc. -1.198

EPS Diluted (Quarterly) Related Metrics